menu
    • menu

    Company profile for Immunocore

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a leading T Cell Receptor (TCR) biotechnology company, focused on delivering first-in-class biological therapies that have the potential to transform the lives of people with serious diseases. Our primary therapeutic focus is oncology, and we also have programs in infectious and autoimmune diseases. We have a pipeline of proprietary and partnered programs in development and our lead program, IMCgp100, has entered pivota...
    We are a leading T Cell Receptor (TCR) biotechnology company, focused on delivering first-in-class biological therapies that have the potential to transform the lives of people with serious diseases. Our primary therapeutic focus is oncology, and we also have programs in infectious and autoimmune diseases. We have a pipeline of proprietary and partnered programs in development and our lead program, IMCgp100, has entered pivotal clinical studies as a treatment for patients with metastatic uveal melanoma. Our partners include Genentech, GlaxoSmithKline, MedImmune (AstraZeneca), Lilly, and the Bill and Melinda Gates Foundation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Immunocoreunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    101 Park Drive Milton Park Abingdon Oxfordshire OX14 4RY UK
    Telephone
    Telephone
    +44 (0)1235 438600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunocore.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immunocore/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/immunocore

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunocore To Present At Upcoming Investor Conferences
    Immunocore To Present At Upcoming Investor Conferences

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184362/0/en/Immunocore-to-present-at-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Immunocore Unveils Hepatitis B Candidate Phase 1 Data at AASLD
    Immunocore Unveils Hepatitis B Candidate Phase 1 Data at AASLD

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183593/0/en/Immunocore-presents-Phase-1-data-for-hepatitis-B-candidate-at-AASLD-s-The-Liver-Meeting.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Enforcement Report - Week of September 10, 2025
    Enforcement Report - Week of September 10, 2025

    10 Sep 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-10-2025-82423.pdf

    FDA
    10 Sep 2025
    Share Share
    Immunocore to present at upcoming investor conferences
    Immunocore to present at upcoming investor conferences

    04 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/04/3144336/0/en/Immunocore-to-present-at-upcoming-investor-conferences.html

    GLOBENEWSWIRE
    04 Sep 2025
    Share Share
    Immunocore Reports Q2 Financial Results
    Immunocore Reports Q2 Financial Results

    07 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/07/3129043/0/en/Immunocore-reports-second-quarter-financial-results-and-provides-a-business-update.html

    GLOBENEWSWIRE
    07 Aug 2025
    Share Share
    Immunocore's Q2 2025 Financial Results and Call on August 7, 2025
    Immunocore's Q2 2025 Financial Results and Call on August 7, 2025

    31 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3124673/0/en/Immunocore-to-report-second-quarter-2025-financial-results-and-host-call-on-August-7-2025.html

    GLOBENEWSWIRE
    31 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search